Bernstein BE, Glaze DG, Rett Syndrome , edited by Pataki C, updated January 5, 2015, available at http://emedicine.medscape.com/article/916377-overview

Ellaway CJ, Peat J, Williams K, Leonard H, Christodoulou J. Medium-term open label trial of L-carnitine in Rett syndrome. Brain Dev. 2001 Dec;23 Suppl 1:S85-9.

Ellaway CJ, Williams K, Leonard H, Higgins G, Wilcken B, Christodoulou J. Rett syndrome: randomized controlled trial of L-carnitine. J Child Neurol. 1999 Mar;14(3):162-7.

De Felice C, Cortelazzo A, Signorini C, Guerranti R, Leoncini S, Pecorelli A, Durand T, Galano JM, Oger C, Zollo G, Montomoli B, Landi C, Bini L, Valacchi G, Ciccoli L, Hayek J. Effects of ω-3 polyunsaturated fatty acids on plasma proteome in Rett syndrome. Mediators Inflamm. 2013;2013:723269, available at http://www.hindawi.com/journals/mi/2013/723269/

De Felice C, Signorini C, Durand T, Ciccoli L, Leoncini S, D’Esposito M, Filosa S, Oger C, Guy A, Bultel-Poncé V, Galano JM, Pecorelli A, De Felice L, Valacchi G, Hayek J. Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil. Genes Nutr. 2012 Jul;7(3):447-58, available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380188/

National Institute of Neurological Disorders and Stroke. Rett syndrome fact sheet. Published in November 2009, last updated February 23, 2015, available at http://www.ninds.nih.gov/disorders/rett/detail_rett.htm

Rett Syndrome Research Trust, available at http://www.rsrt.org/research/